Nuvation Bio Files 2025 Annual Report
Ticker: NUVB · Form: ARS · Filed: Apr 10, 2026 · CIK: 0001811063
| Field | Detail |
|---|---|
| Company | Nuvation Bio Inc. (NUVB) |
| Form Type | ARS |
| Filed Date | Apr 10, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, sec-filing, pharmaceuticals
TL;DR
Nuvation Bio dropped its 2025 ARS on 4/10/26. Check it for deets.
AI Summary
Nuvation Bio Inc. filed an Annual Report to Security Holders (ARS) on April 10, 2026, for the period ending December 31, 2025. The company, headquartered in New York, NY, is involved in the Pharmaceutical Preparations industry. This filing provides a summary of the company's performance and financial standing for the fiscal year 2025.
Why It Matters
This report provides shareholders with a comprehensive overview of Nuvation Bio's activities and financial health for the past fiscal year, crucial for investment decisions.
Risk Assessment
Risk Level: low — This is a routine annual filing and does not contain new material information that would immediately impact risk.
Key Players & Entities
- Nuvation Bio Inc. (company) — Filer
- 0001811063 (company) — CIK
- 2026-04-10 (date) — Filing Date
- 2025-12-31 (date) — Period of Report
- 1500 BROADWAY SUITE 1401 NEW YORK NY 10036 (address) — Mailing and Business Address
FAQ
What type of filing is this?
This is an Annual Report to Security Holders (ARS) filing.
When was this filing accepted by the SEC?
The filing was accepted on April 10, 2026.
What period does this report cover?
The report covers the period ending December 31, 2025.
What is Nuvation Bio Inc.'s CIK number?
Nuvation Bio Inc.'s CIK number is 0001811063.
What industry is Nuvation Bio Inc. in?
Nuvation Bio Inc. is in the Pharmaceutical Preparations industry (SIC code 2834).
Filing Details
This Form ARS (Form ARS) was filed with the SEC on April 10, 2026 regarding Nuvation Bio Inc. (NUVB).